Cost, Insurance Driving Move to Compounded Drugs Compounded GLP-1 medications are not approved by the FDA, and the agency issued a warning in June calling them potentially risky for patients. This hasnt stopped patients from switching to the unapproved drugs, and 35% of patients who took compounded GLP-1s left from a name brand drug, according to Gallup
Pharmacotherapy (2011) 31:896911
Preclinical studies showed that GLP-1RAs reduce cytokine production, attenuate pulmonary inflammation and preserve lung function in rats and mice with experimental lung injury (38, 39)
Bold values are presented as mean SD or number (%)
Primary Research Extensive primary research was conducted after acquiring basic knowledge about the global GLP-1 agonists market scenario through secondary research
REIs system improvements also allowed the Office of the Secretary of Defense to submit reports on time and maintain greater accountability with Congress